Details

Autor(en) / Beteiligte

• Rajesh, Mohanraj
• Pan, Hao
• Mukhopadhyay, Partha
• Bátkai, Sándor
• Osei-Hyiaman, Douglas
• Haskó, György
• Liaudet, Lucas
• Gao, Bin
• Pacher, Pál

Titel

Pivotal Advance: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis

Ist Teil von

• Journal of leukocyte biology, 2007-12, Vol.82 (6), p.1382-1389

Ort / Verlag

Society for Leukocyte Biology

Erscheinungsjahr

2007

Link zum Volltext

Quelle

Wiley Online Library Journals Frontfile Complete

Beschreibungen/Notizen

• In this study, we have investigated the role of the cannabinoid CB2 (CB2) receptor in an in vivo mouse model of hepatic ischemia/reperfusion (I/R) injury. In addition, we have assessed the role of the CB2 receptor in TNF‐α‐induced ICAM‐1 and VCAM‐1 expression in human liver sinusoidal endothelial cells (HLSECs) and in the adhesion of human neutrophils to HLSECs in vitro. The potent CB2 receptor agonist HU‐308, given prior to the induction of I/R, significantly attenuated the extent of liver damage (measured by serum alanine aminotransferase and lactate dehydrogenase) and decreased serum and tissue TNF‐α, MIP‐1α, and MIP‐2 levels, tissue lipid peroxidation, neutrophil infiltration, DNA fragmentation, and caspase 3 activity. The protective effect of HU‐308 against liver damage was also preserved when given right after the ischemic episode. HU‐308 also attenuated the TNF‐α‐induced ICAM‐1 and VCAM‐1 expression in HLSECs, which expressed CB2 receptors, and the adhesion of human neutrophils to HLSECs in vitro. These findings suggest that selective CB2 receptor agonists may represent a novel, protective strategy against I/R injury by attenuating oxidative stress, inflammatory response, and apoptosis.